HLB3-002

N/A

Report date: 2024/08/12 17:58:24

Base Information

Drug NameHLB3-002

Drug Alias NameHLB3-002

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionHyaluronic acid modulators

TargetsHyaluronic acid

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesHuonslab Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHuonslab Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A